5-alpha Reductase Inhibitor class drugs

2 results

  • Entadfi

    (finasteride and tadalafil)
    Veru Inc.
    Usage: ENTADFI is indicated for the initiation of treatment for signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate for up to 26 weeks. Use beyond 26 weeks is not recommended due to decreasing benefits.

  • Jalyn

    (dutasteride and tamsulosin hydrochloride)
    GlaxoSmithKline LLC
    Usage: JALYN (dutasteride and tamsulosin hydrochloride) is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men. It is not approved for the prevention of prostate cancer.